PDGFRα (D842I) Assay Kit

Catalog #
79761
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Platelet-derived growth factor receptor A or PDGFRα has been implicated in regulation of cell growth and survival, apoptosis, and differentiation. It has been identified as a potential target in eosinophilic leukemia cancer, inflammatory breast cancer, and gastrointestinal stromal tumors. The D842 mutation is found in gastrointestinal stromal tumors and is associated with resistance to tyrosine kinase inhibitors. The PDGFRα (D842I) Assay Kit is designed to measure PDGFRα (D842I) activity for screening and profiling applications using Kinase-Glo® MAX as a detection reagent.

Need us to run inhibitor screens or profile your compounds against PDGFRα (D842I)? Check out our Kinase Screening Services.

This product has been cited 2 times.

Synonyms
Platelet Derived Growth Factor Receptor Alpha, CD140 Antigen-Like Family Member A, PDGFR2, CD140a Antigen
Product Info
Storage and Usage
Citations2
Assay Kit Format
Luminescent
Supplied As
The PDGFRα (D842I) Assay Kit comes in a convenient 96-well format, with enough purified recombinant PDGFRα (D842I), Protein Tyrosine Kinase Substrate (Poly-Glu,Tyr 4:1), ATP, and kinase assay buffer for 96 enzyme reactions.
Materials Required But Not Supplied

Kinase-Glo MAX (Promega #V6071)
Dithiothreitol (DTT, 1 M; optional)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator

Format

Catalog #

Reagent

Amount

Storage

100202

PDGFRα (D842I), GST-Tag

10 µg

-80°C

Avoid multiple freeze/ thaw cycles!

79334

5x Kinase Assay Buffer 1

1.5 ml

-20°C

79686

ATP (500 µM)

100 µl

-20°C

40217

Protein Tyrosine Kinase Substrate (Poly-Glu,Tyr 4:1) (10 mg/ml)

100 µl

-20°C

79696

96-well plate, white

1

RT

 

UniProt #
P16234
References

1. Evans, E., et al. A Precision Therapy Against Cancers Driven by KIT/PDGFRA Mutations; 2017, Science Translational Medicine Nov; 9(414): 1690.

2. Joglekar-Javadekar, M., et al. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia. 2017 Jul; 19(7):564-573.

3. Corless, C.L., et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol. 2005 Aug 10; 23(23):5357-64.